<DOC>
	<DOCNO>NCT00386698</DOCNO>
	<brief_summary>Since influenza vaccine normally administer every year frequent change antigenic composition , safety immunogenicity profile adjuvanted influenza vaccine need re-evaluated repeat vaccine administration . In study , subject enrol previous study receive booster dose 2006-2007 season 's formulation Fluarix adjuvanted vaccine .</brief_summary>
	<brief_title>Study Evaluate Reactogenicity Immunogenicity Revaccination With Adjuvanted Influenza Vaccine Elderly Adults</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>The subject must healthy adult age 1840 year &gt; /= 65 year previously vaccinate either Fluarix adjuvanted vaccine . Subjects exclude take/have take chronically high dos immunosuppressant immune modify drug within six month vaccination , immunoglobulins blood product within three month vaccination , investigational product within 30 day vaccination Have history influenza infection since previous vaccination Women pregnant Subjects acute chronic clinically significant disease immunosuppressive/deficient condition , contraindication influenza vaccination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Influenza ,</keyword>
	<keyword>improve vaccine ,</keyword>
	<keyword>influenza disease</keyword>
	<keyword>elderly</keyword>
</DOC>